Insider trades › Julie Rubinstein
Julie Rubinstein
A corporate insider: an officer, director or owner of more than 10% of a company. Insiders report their trades to the SEC on Form 4The form insiders use to report each purchase or sale of their company's stock. It is due within two business days of the trade. · Last filing Nov 13, 2026
Companies
1
where this person reports as an insider
Open-market buys
0
among the latest 91 trades
Open-market sales
91
among the latest 91 trades
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, list Julie Rubinstein's open-market buys and sells across companies in the last two years, with the Form 4 links.
Using 13F.ai, how did the stocks Julie Rubinstein bought perform after the purchase compared with the S&P 500?
Using 13F.ai, are other insiders at the same companies buying or selling at the same time as Julie Rubinstein?
Connect your AI · Plans and the 7-day free trial (card required)
Buying and selling by quarter
Dollars bought and sold on the open market over the last two years.
Bought Sold
By trade date, using the shares and price reported for each trade. Stock grants, option exercises and shares withheld for tax are left out.
Roles
The companies where this person reports as an insider, and their position at each, most recent first.
| Company | Role | Last filed |
|---|---|---|
| ADPT Adaptive Biotechnologies Corporation | President and COO | Nov 13, 2026 |
Roles come from the filings themselves and can change over time.
Latest open-market trades
Purchases and sales at every company, most recent filing first.
| How the stock has done since the trade date, measured against the S&P 500 over the same days. It describes the stock, not the trader's actual gain or loss. | Filing | ||||||
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 11,466 | $28.93 | $331.7K | — | Form 4 ↗ |
| Nov 12, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 11,881 | $29.40 | $349.3K | -1.1% | Form 4 ↗ |
| Nov 11, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 6,898 | $31.22 | $215.4K | -2.3% | Form 4 ↗ |
| Nov 11, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 4,983 | $30.29 | $150.9K | -2.3% | Form 4 ↗ |
| Nov 10, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 9,981 | $29.35 | $292.9K | -1.7% | Form 4 ↗ |
| Nov 10, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 1,900 | $30.41 | $57.8K | -1.7% | Form 4 ↗ |
| Nov 9, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 8,381 | $30.15 | $252.7K | -4.3% | Form 4 ↗ |
| Nov 9, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 1,100 | $28.87 | $31.8K | -4.3% | Form 4 ↗ |
| Nov 9, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 2,400 | $30.58 | $73.4K | -4.3% | Form 4 ↗ |
| Nov 6, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 8,400 | $27.32 | $229.5K | +1.2% | Form 4 ↗ |
| Nov 6, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 3,481 | $27.88 | $97.1K | +1.2% | Form 4 ↗ |
| Nov 5, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 5,926 | $26.10 | $154.7K | +5.3% | Form 4 ↗ |
| Nov 5, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 5,455 | $26.88 | $146.6K | +5.3% | Form 4 ↗ |
| Nov 5, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 500 | $27.70 | $13.8K | +5.3% | Form 4 ↗ |
| Nov 4, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 7,881 | $26.60 | $209.6K | +10.3% | Form 4 ↗ |
| Nov 4, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 4,000 | $25.78 | $103.1K | +10.3% | Form 4 ↗ |
| Nov 3, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 11,881 | $25.98 | $308.7K | +12.6% | Form 4 ↗ |
| Nov 2, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 9,296 | $25.23 | $234.5K | +15.6% | Form 4 ↗ |
| Nov 2, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 2,585 | $26.34 | $68.1K | +15.6% | Form 4 ↗ |
| Oct 30, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 9,486 | $26.55 | $251.9K | +9.2% | Form 4 ↗ |
| Oct 30, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 2,395 | $27.45 | $65.7K | +9.2% | Form 4 ↗ |
| Oct 29, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 11,881 | $28.27 | $335.9K | +5.0% | Form 4 ↗ |
| Oct 28, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 11,681 | $28.44 | $332.2K | +4.7% | Form 4 ↗ |
| Oct 28, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 200 | $28.90 | $5,780 | +4.7% | Form 4 ↗ |
| Oct 27, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 3,000 | $26.58 | $79.7K | +7.0% | Form 4 ↗ |
| Oct 27, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 8,881 | $27.53 | $244.5K | +7.0% | Form 4 ↗ |
| Oct 26, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 3,378 | $26.30 | $88.8K | +12.0% | Form 4 ↗ |
| Oct 26, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 8,503 | $25.94 | $220.6K | +12.0% | Form 4 ↗ |
| Oct 23, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 4,500 | $24.50 | $110.3K | +14.6% | Form 4 ↗ |
| Oct 23, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 7,381 | $25.28 | $186.6K | +14.6% | Form 4 ↗ |
| Oct 22, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 10,181 | $24.38 | $248.2K | +20.2% | Form 4 ↗ |
| Oct 22, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 1,700 | $25.29 | $43.0K | +20.2% | Form 4 ↗ |
| Oct 21, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 5,882 | $25.57 | $150.4K | +17.1% | Form 4 ↗ |
| Oct 21, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 5,999 | $25.25 | $151.5K | +17.1% | Form 4 ↗ |
| Oct 20, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 100 | $24.85 | $2,485 | +20.8% | Form 4 ↗ |
| Oct 20, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 11,781 | $24.53 | $289.0K | +20.8% | Form 4 ↗ |
| Oct 19, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 11,881 | $24.05 | $285.7K | +22.8% | Form 4 ↗ |
| Oct 16, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 300 | $25.45 | $7,635 | +22.1% | Form 4 ↗ |
| Oct 16, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 11,581 | $24.21 | $280.4K | +22.1% | Form 4 ↗ |
| Oct 15, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 11,881 | $25.61 | $304.3K | +15.8% | Form 4 ↗ |
| Oct 14, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 5,100 | $25.82 | $131.7K | +15.3% | Form 4 ↗ |
| Oct 14, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 6,781 | $25.57 | $173.4K | +15.3% | Form 4 ↗ |
| Apr 27, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,037 | $14.23 | $270.9K | +98.9% | Form 4 ↗ |
| Apr 24, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $14.02 | $267.2K | +99.7% | Form 4 ↗ |
| Apr 23, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $13.74 | $261.9K | +103.6% | Form 4 ↗ |
| Apr 22, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $14.13 | $269.3K | +98.4% | Form 4 ↗ |
| Apr 21, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 30,941 | $14.66 | $453.6K | +97.2% | Form 4 ↗ |
| Apr 20, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $14.55 | $277.3K | +92.7% | Form 4 ↗ |
| Apr 17, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $14.57 | $277.7K | +94.5% | Form 4 ↗ |
| Apr 16, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $14.18 | $270.3K | +98.7% | Form 4 ↗ |
| Apr 15, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $14.61 | $278.5K | +92.1% | Form 4 ↗ |
| Apr 14, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $14.56 | $277.5K | +91.2% | Form 4 ↗ |
| Apr 13, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 3,338 | $14.08 | $47.0K | +95.6% | Form 4 ↗ |
| Apr 13, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 15,722 | $12.95 | $203.6K | +95.6% | Form 4 ↗ |
| Apr 10, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 400 | $13.48 | $5,392 | +116.0% | Form 4 ↗ |
| Apr 10, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 18,660 | $12.75 | $237.9K | +116.0% | Form 4 ↗ |
| Apr 9, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 2,100 | $14.44 | $30.3K | +105.8% | Form 4 ↗ |
| Apr 9, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 16,960 | $13.79 | $233.9K | +105.8% | Form 4 ↗ |
| Apr 8, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 30,841 | $14.83 | $457.4K | +84.1% | Form 4 ↗ |
| Apr 8, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 100 | $15.48 | $1,548 | +84.1% | Form 4 ↗ |
| Apr 7, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $13.56 | $258.5K | +97.4% | Form 4 ↗ |
| Apr 6, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $14.33 | $273.1K | +91.8% | Form 4 ↗ |
| Apr 2, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $14.60 | $278.3K | +81.1% | Form 4 ↗ |
| Apr 1, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $14.45 | $275.4K | +86.1% | Form 4 ↗ |
| Mar 31, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $13.45 | $256.4K | +93.2% | Form 4 ↗ |
| Mar 30, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $12.63 | $240.7K | +106.6% | Form 4 ↗ |
| Mar 27, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 16,322 | $13.48 | $220.0K | +115.0% | Form 4 ↗ |
| Mar 27, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 2,738 | $12.49 | $34.2K | +115.0% | Form 4 ↗ |
| Mar 26, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $14.12 | $269.1K | +91.1% | Form 4 ↗ |
| Mar 25, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $14.27 | $272.0K | +90.4% | Form 4 ↗ |
| Mar 24, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $13.70 | $261.1K | +93.4% | Form 4 ↗ |
| Mar 23, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $13.83 | $263.6K | +97.5% | Form 4 ↗ |
| Mar 20, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $13.37 | $254.8K | +97.5% | Form 4 ↗ |
| Mar 19, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $13.18 | $251.2K | +100.8% | Form 4 ↗ |
| Mar 18, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $13.18 | $251.2K | +104.6% | Form 4 ↗ |
| Mar 17, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $13.40 | $255.4K | +104.4% | Form 4 ↗ |
| Mar 16, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $13.41 | $255.6K | +105.3% | Form 4 ↗ |
| Mar 13, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $12.96 | $247.0K | +106.6% | Form 4 ↗ |
| Mar 12, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 13,660 | $12.63 | $172.5K | +120.0% | Form 4 ↗ |
| Mar 12, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 5,400 | $13.43 | $72.5K | +120.0% | Form 4 ↗ |
| Mar 11, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 122,523 | $13.17 | $1.6M | +92.7% | Form 4 ↗ |
| Mar 11, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,060 | $14.08 | $268.4K | +92.7% | Form 4 ↗ |
| Mar 10, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,460 | $14.68 | $285.7K | +88.6% | Form 4 ↗ |
| Mar 9, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 30,941 | $14.79 | $457.6K | +83.0% | Form 4 ↗ |
| Mar 6, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 30,941 | $15.14 | $468.4K | +83.2% | Form 4 ↗ |
| Mar 5, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 30,941 | $16.00 | $495.1K | +71.6% | Form 4 ↗ |
| Mar 4, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 30,941 | $16.60 | $513.6K | +66.5% | Form 4 ↗ |
| Mar 3, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 6,518 | $16.33 | $106.4K | +69.7% | Form 4 ↗ |
| Mar 3, 2026 | ADPT Adaptive Biotechnologies Corporation | Sale | 24,423 | $15.49 | $378.3K | +69.7% | Form 4 ↗ |
| Mar 5, 2025 | ADPT Adaptive Biotechnologies Corporation | Sale | 40,044 | $6.98 | $279.5K | +232.3% | Form 4 ↗ |
| Mar 5, 2025 | ADPT Adaptive Biotechnologies Corporation | Sale | 19,461 | $6.99 | $136.0K | +232.3% | Form 4 ↗ |
Each row links to its Form 4. Since trade compares the stock’s move from the close on the trade date (or the next trading day) to its latest close with the S&P 500 over the same days, adjusted for splits and excluding dividends. It describes the stock, not what the trader made: we don’t know their purchase price, position size or later sales. A dash means the trade isn’t matched to a listed stock, or there is no closing price after it yet.
When several people report on the same filing, we list it under the first one named, so trades by someone usually listed second may be missing here. Information, not investment advice: see the disclaimer.